Literature DB >> 23321049

White matter microstructural integrity and executive function in Parkinson's disease.

Catherine Gallagher1, Brian Bell, Barbara Bendlin, Matthew Palotti, Ozioma Okonkwo, Aparna Sodhi, Rachel Wong, Laura Buyan-Dent, Sterling Johnson, Auriel Willette, Auriel Wilette, Sandra Harding, Nancy Ninman, Erik Kastman, Andrew Alexander.   

Abstract

Recent studies suggest that white matter abnormalities contribute to both motor and non-motor symptoms of Parkinson’s disease. The present study was designed to investigate the degree to which diffusion tensor magnetic resonance imaging (DTI) indices are related to executive function in Parkinson’s patients. We used tract-based spatial statistics to compare DTI data from 15 patients to 15 healthy, age- and education-matched controls. We then extracted mean values of fractional anisotropy (FA) and mean diffusivity (MD) within an a priori frontal mask. Executive function composite Z scores were regressed against these DTI indices, age, and total intracranial volume. In Parkinson’s patients, FA was related to executive composite scores, and both indices were related to Stroop interference scores. We conclude that white matter microstructural abnormalities contribute to cognitive deficits in Parkinson’s disease. Further work is needed to determine whether these white matter changes reflect the pathological process or a clinically important comorbidity.

Entities:  

Mesh:

Year:  2013        PMID: 23321049      PMCID: PMC3637933          DOI: 10.1017/S1355617712001373

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  18 in total

Review 1.  Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).

Authors:  Heiko Braak; Kelly Del Tredici; Hansjürgen Bratzke; John Hamm-Clement; Daniele Sandmann-Keil; Udo Rüb
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

2.  The measurement of creativity by the Stroop Color and Word Test.

Authors:  C J Golden
Journal:  J Pers Assess       Date:  1975-10

Review 3.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex.

Authors:  G E Alexander; M R DeLong; P L Strick
Journal:  Annu Rev Neurosci       Date:  1986       Impact factor: 12.449

4.  A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging.

Authors:  P Scheltens; F Barkhof; D Leys; J P Pruvo; J J Nauta; P Vermersch; M Steinling; J Valk
Journal:  J Neurol Sci       Date:  1993-01       Impact factor: 3.181

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Stroop performance in focal lesion patients: dissociation of processes and frontal lobe lesion location.

Authors:  D T Stuss; D Floden; M P Alexander; B Levine; D Katz
Journal:  Neuropsychologia       Date:  2001       Impact factor: 3.139

7.  Utility of a Wisconsin Card Sorting Test short form in persons with Alzheimer's and Parkinson's disease.

Authors:  A M Paolo; B N Axelrod; A I Tröster; K T Blackwell; W C Koller
Journal:  J Clin Exp Neuropsychol       Date:  1996-12       Impact factor: 2.475

Review 8.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

9.  Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.

Authors:  S M de la Monte; S E Wells; T Hedley-Whyte; J H Growdon
Journal:  Ann Neurol       Date:  1989-09       Impact factor: 10.422

10.  White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function.

Authors:  Charlotte L Rae; Marta M Correia; Ellemarije Altena; Laura E Hughes; Roger A Barker; James B Rowe
Journal:  Neuroimage       Date:  2012-06-17       Impact factor: 6.556

View more
  19 in total

1.  Longitudinal white matter microstructural change in Parkinson's disease.

Authors:  Vincent Pozorski; Jennifer M Oh; Nagesh Adluru; Andrew P Merluzzi; Frances Theisen; Ozioma Okonkwo; Amy Barzgari; Stephanie Krislov; Jitka Sojkova; Barbara B Bendlin; Sterling C Johnson; Andrew L Alexander; Catherine L Gallagher
Journal:  Hum Brain Mapp       Date:  2018-06-27       Impact factor: 5.038

2.  Considering total intracranial volume and other nuisance variables in brain voxel based morphometry in idiopathic PD.

Authors:  Samuel Crowley; Haiqing Huang; Jared Tanner; Qing Zhao; Nadine A Schwab; Loren Hizel; Daniel Ramon; Babette Brumback; Mingzhou Ding; Catherine C Price
Journal:  Brain Imaging Behav       Date:  2018-02       Impact factor: 3.978

3.  Anterior cingulate dopamine turnover and behavior change in Parkinson's disease.

Authors:  Catherine L Gallagher; Brian Bell; Matthew Palotti; Jen Oh; Bradley T Christian; Ozioma Okonkwo; Jitka Sojkova; Laura Buyan-Dent; Robert J Nickles; Sandra J Harding; Charles K Stone; Sterling C Johnson; James E Holden
Journal:  Brain Imaging Behav       Date:  2015-12       Impact factor: 3.978

Review 4.  Cerebellar Microstructural Abnormalities in Parkinson's Disease: a Systematic Review of Diffusion Tensor Imaging Studies.

Authors:  Maryam Haghshomar; Parnian Shobeiri; Seyed Arsalan Seyedi; Fatemeh Abbasi-Feijani; Amirhossein Poopak; Houman Sotoudeh; Arash Kamali; Mohammad Hadi Aarabi
Journal:  Cerebellum       Date:  2022-01-10       Impact factor: 3.648

5.  What does the Dementia Rating Scale-2 measure? The relationship of neuropsychological measures to DRS-2 total and subscale scores in non-demented individuals with Parkinson's disease.

Authors:  Francesca V Lopez; Lauren E Kenney; Adrianna Ratajska; Charles E Jacobson; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2021-11-15       Impact factor: 4.373

6.  Imaging changes associated with cognitive abnormalities in Parkinson's disease.

Authors:  Yuko Koshimori; Barbara Segura; Leigh Christopher; Nancy Lobaugh; Sarah Duff-Canning; Romina Mizrahi; Clement Hamani; Anthony E Lang; Kelly Aminian; Sylvain Houle; Antonio P Strafella
Journal:  Brain Struct Funct       Date:  2014-05-13       Impact factor: 3.270

Review 7.  The evolving role of diffusion magnetic resonance imaging in movement disorders.

Authors:  Christopher W Hess; Edward Ofori; Umer Akbar; Michael S Okun; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

8.  Statistically Defined Parkinson's Disease Executive and Memory Cognitive Phenotypes: Demographic, Behavioral, and Structural Neuroimaging Comparisons.

Authors:  Samuel J Crowley; Guita Banan; Manish Amin; Jared J Tanner; Loren Hizel; Peter Nguyen; Babette Brumback; Katie Rodriguez; Nikolaus McFarland; Dawn Bowers; Mingzhou Ding; Thomas A Mareci; Catherine C Price
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

9.  Neuropsychological Characteristics and Their Association with Higher-Level Functional Capacity in Parkinson's Disease.

Authors:  Kayoko Miura; Mie Matsui; Shutaro Takashima; Kortaro Tanaka
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-06-19

10.  White-matter changes correlate with cognitive functioning in Parkinson's disease.

Authors:  Rebecca J Theilmann; Jason D Reed; David D Song; Mingxiong X Huang; Roland R Lee; Irene Litvan; Deborah L Harrington
Journal:  Front Neurol       Date:  2013-04-12       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.